Abstract
The overall objective of this study was to compare bioavailability of acyclovir (ACV) in Sprague‐Dawley (SD) rats following oral administration of the ACV prodrugs valacyclovir and val‐valacyclovir (10 mg/kg body weight ACV equivalent). ACV, valacyclovir and val‐valacyclovir were estimated using a high pressure liquid chromatography system equipped with a fluorescence detector. Intact prodrugs, valacyclovir and val‐valacyclovir could not be detected in the plasma. Differences in Cmax (4.47 ± 1.68 µg/ml and 2.92 ± 0.90 µg/ml), Tmax (51.66 ± 27.14 and 27.14 and 25.83 ± 11.14 min) and AUC (366.02 ± 146.78 and 231.3 ± 90.88 min. µg/ml) achieved for ACV derived from valacyclovir and val‐valacyclovir, respectively, were not statistically significant. Val‐valacyclovir was rapidly hydrolyzed in rat enterocyte and whole intestinal homogenates (half‐lives of 6.5 and 15 min respectively) and plasma (half‐life of 8.4 min). Valacyclovir demonstrated comparatively longer half‐lives in plasma (half‐life 466.9 min) and w...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
